COSCIENS Biopharma Inc. revenue by segment CSCIF

Annual Quarterly

COSCIENS Biopharma Inc. splits its revenue into 9 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Active Ingredients at $7.0 million, 94% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018	FY 2017 Dec 31, 2017
Revenue	7	10	7	15	5	4	1	27	1
Active Ingredients	7 -17.1% share 93.9%	8 +18.9% share 88.6%	7 share 100.0%	—	—	—	—	—	—
Development Services Novo Amendment	—	—	—	—	3 share 63.4%	—	—	—	—
Novo Supply Agreement	—	—	—	—	—	2 share 64.9%	—	—	—
License Novo Amendment	—	—	—	—	2 +98.1% share 31.7%	1 share 23.1%	—	—	—
Biopharmaceutical	0 -57.9% share 6.1%	1 share 11.4%	—	—	—	—	—	—	—
Novo Supply Agreements	—	—	—	—	0 -39.1% share 3.5%	0 +7.0% share 8.3%	0 share 53.4%	—	—
License Strongbridge Agreement	—	—	—	—	—	—	0 share 13.9%	—	—
Royalties Novo Amendment	—	—	—	—	0 +518.2% share 1.3%	0 share 0.3%	—	—	—
Royalties Strongbridge Agreement	—	—	—	—	—	0 +24.4% share 1.5%	0 share 8.5%	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. More on our methodology.

Company profile

Industry: Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844)
Listed as: CSCIF (OTC)
Fiscal year ends: December 31
Incorporated in: Ontario, Canada
Headquarters: Toronto, Ontario, Canada
SEC filer status: Non-accelerated filer
SEC CIK: 1113423
Former names: Aeterna Zentaris Inc. (until Aug 7, 2024); AETERNA LABORATORIES INC (until May 25, 2004)

Other Perfumes, Cosmetics & Other Toilet Preparations companies

All 22 Perfumes, Cosmetics & Other Toilet Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.